Guidance Document: Preparation of Clinical Trial Applications for use of Cell Therapy Products in Humans

The purpose of this guidance is to provide information to prospective cell therapy product clinical trial sponsors to assist them in satisfying applicable Federal regulatory requirements as set out in Division 5 – Clinical Trial Applications of the Food and Drug Regulations.

Publisher
Health Canada
Resources
2
Catalogue metadata updated
2021-06-02

Data overview

Formats
HTML
File languages
English, French

Official sources and licences

Resources

Related open data